Carbetocin

Generic Name: Carbetocin

Brand Names: Duratocin

Drug Type: Small Molecule

Chemical Formula: C_₄₅H_₆₉N_₁₁O_₁₂S

CAS Number: 37025-55-1

Unique Ingredient Identifier: 88TWF8015Y

Background: Carbetocin is a drug used to control postpartum hemorrhage, bleeding after giving birth. It is an analogue of oxytocin, and its action is similar to that of oxytocin -- it causes contraction of the uterus.

Indication: Used to control postpartum hemorrhage and bleeding after giving birth.

Associated Conditions: Postpartum Haemorrhage (PPH), Uterine Atony

Associated Therapies: -

Clinical Trials

Carbetocin at Elective Cesarean Delivery

Not Applicable

Completed

Conditions: Postpartum Hemorrhage

Interventions: Drug: Carbetocin

First Posted Date: 2010-12-17

Last Posted Date: 2011-09-05

Lead Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital

Target Recruit Count: 80

Registration Number: NCT01262742

Locations: 🇨🇦
Mount Sinai Hospital, Toronto, Ontario, Canada

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy